[Regional microcirculatory disorders in peritonitis]. 1987

V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev

Investigations performed under experimental and clinical conditions have shown that regional microcirculatory alterations in peritonitis consist in the arterial spasm, arteriovenous shunt of blood, hypoperfusion of the intestine, local metabolic disorders. The application of alpha-adrenoblockaders is recommended for directed action on microcirculation with an obligatory correction of deficit of the circulating blood volume.

UI MeSH Term Description Entries
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000317 Adrenergic alpha-Antagonists Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. Adrenergic alpha-Receptor Blockaders,alpha-Adrenergic Blocking Agents,alpha-Adrenergic Receptor Blockaders,alpha-Blockers, Adrenergic,Adrenergic alpha-Blockers,alpha-Adrenergic Antagonists,alpha-Adrenergic Blockers,Adrenergic alpha Antagonists,Adrenergic alpha Blockers,Adrenergic alpha Receptor Blockaders,Agents, alpha-Adrenergic Blocking,Antagonists, alpha-Adrenergic,Blockaders, Adrenergic alpha-Receptor,Blockaders, alpha-Adrenergic Receptor,Blockers, alpha-Adrenergic,Blocking Agents, alpha-Adrenergic,Receptor Blockaders, alpha-Adrenergic,alpha Adrenergic Antagonists,alpha Adrenergic Blockers,alpha Adrenergic Blocking Agents,alpha Adrenergic Receptor Blockaders,alpha Blockers, Adrenergic,alpha-Antagonists, Adrenergic,alpha-Receptor Blockaders, Adrenergic

Related Publications

V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev
September 1980, Khirurgiia,
V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev
April 1982, Khirurgiia,
V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev
January 1981, Anesteziologiia i reanimatologiia,
V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev
July 1969, Kardiologiia,
V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev
July 1982, Klinicheskaia meditsina,
V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev
January 2000, Current medical research and opinion,
V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev
August 1977, Voenno-meditsinskii zhurnal,
V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev
January 1978, Vestnik khirurgii imeni I. I. Grekova,
V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev
January 2001, European radiology,
V T Zaĭtsev, and Iu L Shal'kov, and V M Revin, and A V Lazarev
January 1985, Vestnik khirurgii imeni I. I. Grekova,
Copied contents to your clipboard!